743P Combined analysis of overall survival (OS) from the phase III CodeBreaK 300 and phase Ib CodeBreaK 101 studies of sotorasib 960 mg plus panitumumab (soto960+pani) therapy for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC).
Saved in:
| Title: | 743P Combined analysis of overall survival (OS) from the phase III CodeBreaK 300 and phase Ib CodeBreaK 101 studies of sotorasib 960 mg plus panitumumab (soto960+pani) therapy for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). |
|---|---|
| Authors: | Kuboki, Y.1 (AUTHOR), Pietrantonio, F.2 (AUTHOR), Salvatore, L.3 (AUTHOR), Meriggi, F.A.4 (AUTHOR), Modest, D.P.5 (AUTHOR), Yaeger, R.6 (AUTHOR), Ruiz, E.7 (AUTHOR), Taieb, J.8 (AUTHOR), Karamouzis, M.V.9 (AUTHOR), Esaki, T.10 (AUTHOR), Kim, T.W.11 (AUTHOR), Cremolini, C.12 (AUTHOR), Strickler, J.H.13 (AUTHOR), Masuishi, T.14 (AUTHOR), Paez, D.15 (AUTHOR), Chan, E.16 (AUTHOR), Chao, J.16 (AUTHOR), Tran, Q.17 (AUTHOR), Fakih, M.18 (AUTHOR), Hong, D.S.19 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS518-S519. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189419132 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 743P Combined analysis of overall survival (OS) from the phase III CodeBreaK 300 and phase Ib CodeBreaK 101 studies of sotorasib 960 mg plus panitumumab (soto960+pani) therapy for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kuboki%2C+Y%2E%22">Kuboki, Y.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pietrantonio%2C+F%2E%22">Pietrantonio, F.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salvatore%2C+L%2E%22">Salvatore, L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meriggi%2C+F%2EA%2E%22">Meriggi, F.A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Modest%2C+D%2EP%2E%22">Modest, D.P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yaeger%2C+R%2E%22">Yaeger, R.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ruiz%2C+E%2E%22">Ruiz, E.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Taieb%2C+J%2E%22">Taieb, J.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karamouzis%2C+M%2EV%2E%22">Karamouzis, M.V.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Esaki%2C+T%2E%22">Esaki, T.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+T%2EW%2E%22">Kim, T.W.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cremolini%2C+C%2E%22">Cremolini, C.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strickler%2C+J%2EH%2E%22">Strickler, J.H.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Masuishi%2C+T%2E%22">Masuishi, T.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Paez%2C+D%2E%22">Paez, D.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chan%2C+E%2E%22">Chan, E.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chao%2C+J%2E%22">Chao, J.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tran%2C+Q%2E%22">Tran, Q.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fakih%2C+M%2E%22">Fakih, M.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hong%2C+D%2ES%2E%22">Hong, D.S.</searchLink><relatesTo>19</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS518-S519. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419132 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.1317 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S518 Titles: – TitleFull: 743P Combined analysis of overall survival (OS) from the phase III CodeBreaK 300 and phase Ib CodeBreaK 101 studies of sotorasib 960 mg plus panitumumab (soto960+pani) therapy for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kuboki, Y. – PersonEntity: Name: NameFull: Pietrantonio, F. – PersonEntity: Name: NameFull: Salvatore, L. – PersonEntity: Name: NameFull: Meriggi, F.A. – PersonEntity: Name: NameFull: Modest, D.P. – PersonEntity: Name: NameFull: Yaeger, R. – PersonEntity: Name: NameFull: Ruiz, E. – PersonEntity: Name: NameFull: Taieb, J. – PersonEntity: Name: NameFull: Karamouzis, M.V. – PersonEntity: Name: NameFull: Esaki, T. – PersonEntity: Name: NameFull: Kim, T.W. – PersonEntity: Name: NameFull: Cremolini, C. – PersonEntity: Name: NameFull: Strickler, J.H. – PersonEntity: Name: NameFull: Masuishi, T. – PersonEntity: Name: NameFull: Paez, D. – PersonEntity: Name: NameFull: Chan, E. – PersonEntity: Name: NameFull: Chao, J. – PersonEntity: Name: NameFull: Tran, Q. – PersonEntity: Name: NameFull: Fakih, M. – PersonEntity: Name: NameFull: Hong, D.S. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
